Medicare Part D Prescribing

This section is a breakdown of prescribing records for Cyclobenzaprine through the Medicare Prescription Drug Plan throughout 2013. It should be noted that aggregate prescription numbers and costs are not representative of the total prescribing numbers for Cyclobenzaprine across all age groups and insurance plans.

Total Medicare Expense
$$$$$
$49.1
million
Number of Patients
1.55
million
Total Claim Count
4.42
million
Brand Name Combination Generics Manufacturers Type
 Benzaday (15mg) Sun Pharmaceutical IndustriesLtd Capsule
 Diclobenz (1%/3%/3%/2%) Diclofenac 1% w/w +Linseed Oil 3% w/w+ Methyl Salicylate 3% w/w+Cyclobenzaprine 2% w/w Macleods (Pharma) Topical Gel
 Flexabenz (15mg) (15mg) Cyclobenzaprine 15mg Macleods (Gencare) Extended Release Capsule
 Flexabenz (5mg) (5mg) Cyclobenzaprine 5mg Macleods (Gencare) Tablet
 Flexabenz ER (15mg) Macleods Pharmaceuticals PvtLtd Tablet
 Flexabenz Plus (15mg/200mg) (15mg/200mg) Cyclobenzaprine 15mg + Aceclofenac 200mg Macleods (Gencare) Sustained Release Tablet
 Mobrine IR (10mg) Ranbaxy LaboratoriesLtd, Tablet
 Mobrine IR (5mg) Ranbaxy LaboratoriesLtd, Tablet
 Mobrine OD (30mg) Ranbaxy LaboratoriesLtd, Capsule
 Skelebenz (15mg) Sun Pharmaceutical IndustriesLtd Tablet